Biotech Stocks Rally Amid Hantavirus Concerns

Modern Day Biotechnology stocks like Moderna (MRNA), Novavax, and Inovio have seen significant gains due to concerns over a hantavirus outbreak. However, health officials note the risk is 'extremely low.' Investors are cautioned against making rash decisions based on short-term events.

By Bram Berkowitz · Motley Fool ·

Biotech Stocks Rally Amid Hantavirus Concerns

Tickers: $INO $MRNA $NVAX

Topics: hantavirus Inovio Moderna Novavax stock market reaction

Read the full article at Motley Fool

More World news